Reference | </br>1:Vesnarinone suppresses TNFα mRNA expression by inhibiting valosin-containing protein. Hotta K, Nashimoto A, Yasumura E, Suzuki M, Azuma M, Iizumi Y, Shima D, Nabeshima R, Hiramoto M, Okada A, Sakata-Sogawa K, Tokunaga M, Ito T, Ando H, Sakamoto S, Kabe Y, Aizawa S, Imai T, Yamaguchi Y, Watanabe H, Handa H.Mol Pharmacol. 2013 May;83(5):930-8. doi: 10.1124/mol.112.081935. Epub 2013 Feb 7. PMID: 23393163 Free Article</br>2:Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells. Uchida D, Onoue T, Begum NM, Kuribayashi N, Tomizuka Y, Tamatani T, Nagai H, Miyamoto Y.Mol Cancer. 2009 Aug 12;8:62. doi: 10.1186/1476-4598-8-62. PMID: 19671192 Free PMC Article</br>3:Vesnarinone represses the fibrotic changes in murine lung injury induced by bleomycin. Inage M, Nakamura H, Saito H, Abe S, Hino T, Takabatake N, Terashita K, Ogura M, Kato S, Hosokawa T, Sata M, Tomoike H.Int J Biol Sci. 2009;5(4):304-10. Epub 2009 Apr 16. PMID: 19381349 Free PMC Article</br>4:Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8. Harada K, Supriatno, Yoshida H, Sato M.Int J Oncol. 2005 Dec;27(6):1489-97. PMID: 16273203 </br>5:A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo. Gardner I, Popović M, Zahid N, Uetrecht JP.Chem Res Toxicol. 2005 Sep;18(9):1384-94. PMID: 16167830 </br>6:Vesnarinone-mediated alterations of gene expression in cardiac fibroblasts from aortic regurgitant hearts. Truter SL, Dumlao TF, Lee JA, Lee E, Supino PG, Borer JS.Am J Ther. 2004 Sep-Oct;11(5):328-36. PMID: 15356428 </br>7:Precautions for use and adverse effects of vesnarinone: potential mechanisms and future therapies. Bertolet BD.Drug Saf. 2004;27 Suppl 1:11-8. Review. PMID: 15293849 </br>8:Clinical characteristics of vesnarinone. Feldman AM.Drug Saf. 2004;27 Suppl 1:1-9. Review. PMID: 15293848 </br>9:The best of times, the worst of times: the wealth and poverty of heart failure pharmacotherapies: is there a role for vesnarinone? Young JB.Drug Saf. 2004;27 Suppl 1:3 p following table of contents. No abstract available. PMID: 15293847 </br>10:Extended application of an LC-MS/MS method for the analysis of vesnarinone and its metabolites in human urine and dialysate fluid. Sekar KS, Bramer SL.J Pharm Biomed Anal. 2003 Nov 24;33(4):711-7. PMID: 14623597
|